Literature DB >> 2170823

Risks of estrogens and progestogens.

M L'Hermite1.   

Abstract

Keywords:  Biology; Breast Cancer; Cancer; Carbohydrate Metabolic Effects; Cardiovascular Effects; Cerebrovascular Effects; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Cyproterone Acetate; Demographic Factors; Desogestrel; Diseases; Embolism; Endocrine System; Endometrial Cancer; Estradiol; Estriol; Estrogenic Substances, Conjugated; Estrogens; Estrone; Ethinyl Estradiol; Family Planning; Gallbladder Diseases; Gestodene; Glucose Metabolism Effects; Hematological Effects; Hemic System; Hormone Antagonists; Hormones; Hypertension; Levonorgestrel; Lipid Metabolic Effects; Lipids; Literature Review; Lynestrenol; Medroxyprogesterone Acetate; Menopause; Metabolic Effects; Mortality--women; Neoplasms; Norethindrone; Norgestimate; Physiology; Population; Population Dynamics; Reproduction; Risk Factors; Serum Protein Effects; Thromboembolism; Vascular Diseases

Mesh:

Substances:

Year:  1990        PMID: 2170823     DOI: 10.1016/0378-5122(90)90005-q

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


× No keyword cloud information.
  4 in total

Review 1.  Best practice in primary care pathology: review 2.

Authors:  W S Smellie; J O Forth; C A M McNulty; L Hirschowitz; D Lilic; R Gosling; D Bareford; E Logan; K G Kerr; G P Spickett; J Hoffman; A Galloway; C A Bloxham
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.

Authors:  M Stomati; B Hartmann; A Spinetti; D Mailand; S Rubino; A Albrecht; J Huber; F Petraglia; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

3.  Doctor, should I take hormones?

Authors:  Laura Kale
Journal:  Perm J       Date:  2005

4.  Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause.

Authors:  D Marchesoni; M Dal Pozzo; L Dal Magro; D M Paternoster; E Ferroni; T Maggino; C Romagnolo; B Mozzanega
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.